Spire Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Spire Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.17K	Hold	52	–	–	﹤0.01%	1783
2026 Q1	$5.4K	Hold	52	–	–	﹤0.01%	1820
2025 Q4	$5.42K	Hold	52	–	–	﹤0.01%	1898
2025 Q3	$4.78K	Hold	52	–	–	﹤0.01%	1967
2025 Q2	$4.12K	Sell	52 -813	-94%	-$64.9K	﹤0.01%	2006
2025 Q1	$75K	Hold	865	–	–	﹤0.01%	1150
2024 Q4	$71.5K	Hold	865	–	–	﹤0.01%	1153
2024 Q3	$75.2K	Buy	865 +51	+6%	+$4.36K	﹤0.01%	1002
2024 Q2	$66.9K	Hold	814	–	–	﹤0.01%	1021
2024 Q1	$65.3K	Hold	814	–	–	﹤0.01%	1124
2023 Q4	$62.2K	Hold	814	–	–	﹤0.01%	1129
2023 Q3	$58.9K	Hold	814	–	–	﹤0.01%	1114
2023 Q2	$61.6K	Sell	814 -1,000	-55%	-$76.3K	﹤0.01%	1123
2023 Q1	$138K	Hold	1,814	–	–	0.01%	857
2022 Q4	$143K	Hold	1,814	–	–	0.01%	634
2022 Q3	$129K	Hold	1,814	–	–	0.01%	631
2022 Q2	$136K	Hold	1,814	–	–	0.01%	911
2022 Q1	$144K	Sell	1,814 -300	-14%	-$23.3K	﹤0.01%	1035
2021 Q4	$172K	Sell	2,114 -814	-28%	-$64.3K	﹤0.01%	1158
2021 Q3	$227K	Buy	2,928 +300	+11%	+$24.2K	0.01%	869
2021 Q2	$211K	Sell	2,628 -135	-5%	-$10.7K	0.01%	926
2021 Q1	$218K	Buy	+2,763	New	+$216K	0.01%	1028

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Spire Wealth Management's PJP Position: Q2 2026 in Review

Spire Wealth Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 52 shares worth $6.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1783.

Spire Wealth Management first reported a position in PJP in Q1 2021 and has held it in 22 quarters since. The position peaked at $227K in Q3 2021. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Spire Wealth Management held 52 shares of Invesco Pharmaceuticals ETF worth $6.17K as of Q2 2026.
Spire Wealth Management left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1783 holding.
Spire Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2021 and has held it in 22 quarters since.
Spire Wealth Management's Invesco Pharmaceuticals ETF position peaked at $227K in Q3 2021.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.